Renee Alsisto-Pagatpatan
Physician Assistant · Long Beach, CANPI 1447491980
Payments from drug & device makers
Across 367 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$923
- Amgen$819
- Bayer$612
- Lilly USA, LLC$586
- Astellas Pharma US Inc$463
- plus $3K from 33 others
What the payments were for
- Food & beverage$7,51297%
- Education$2063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $1,134 |
| Novo Nordisk | 54 | $923 |
| Amgen(2 entities) | 37 | $819 |
| Bayer | 22 | $612 |
| Lilly USA, LLC | 27 | $586 |
| Astellas Pharma US Inc | 17 | $463 |
| GSK | 18 | $379 |
| Pfizer | 12 | $299 |
| Amarin Pharma, Inc. | 21 | $276 |
| Dexcom, Inc. | 12 | $272 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $264 |
| Esperion Therapeutics, Inc. | 8 | $172 |
| Boehringer Ingelheim | 8 | $165 |
| Vanda Pharmaceuticals Inc. | 6 | $157 |
| Johnson & Johnson | 9 | $151 |
| Sanofi-aventis U.S. LLC | 6 | $123 |
| Merck | 6 | $114 |
| Novartis | 5 | $85 |
| Shield Therapeutics Inc | 3 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $77 |
| Kowa Pharmaceuticals America, Inc. | 5 | $72 |
| Sumitomo Pharma America, Inc. | 2 | $63 |
| Ardelyx, Inc. | 2 | $51 |
| AbbVie | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Exact Sciences | 1 | $30 |
| Radius Health, Inc. | 1 | $26 |
| Ironwood Pharmaceuticals, Inc | 1 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $23 |
| Optinose US, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $17 |
| Metacel Pharmaceuticals LLC | 1 | $17 |
| Phadia US Inc. | 1 | $14 |
| Abbott | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$7,718 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 170 | $168,344 |
| JardianceEmpagliflozin | 123 | $138,681 |
| RybelsusSemaglutide | 98 | $125,166 |
| OzempicSemaglutide | 68 | $74,325 |
| JanuviaSitagliptin Phosphate | 56 | $61,082 |
| EliquisApixaban | 44 | $46,412 |
| Xigduo XrDapaglifloz Propaned/Metformin | 49 | $43,375 |
| LinzessLinaclotide | 41 | $41,405 |
| TrulicityDulaglutide | 40 | $38,316 |
| KerendiaFinerenone | 42 | $32,223 |
| VascepaIcosapent Ethyl | 64 | $30,401 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 38 | $29,647 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $29,241 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 37 | $26,697 |
| TradjentaLinagliptin | 20 | $26,434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $923 | $199,491166 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $165 | $191,812180 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,134 | $182,140193 claims |
| MerckJanuvia, Janumet, Belsomra | $114 | $85,01183 claims |
| PfizerEliquis, Nurtec Odt | $299 | $68,89855 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $379 | $48,40484 claims |
| AbbVieLinzess | $51 | $41,40541 claims |
| Lilly USA, LLCTrulicity | $586 | $38,31640 claims |
| BayerKerendia | $612 | $32,22342 claims |
| Johnson & JohnsonXarelto | $151 | $21,14917 claims |
| Astellas Pharma US IncMyrbetriq | $463 | $9,58616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Long Beach
- Amanda NelsonLong Beach$45K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.